IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.149
NA - Nord America 14.584
AS - Asia 2.311
Continente sconosciuto - Info sul continente non disponibili 72
AF - Africa 9
SA - Sud America 9
OC - Oceania 1
Totale 32.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.545
IE - Irlanda 5.556
SE - Svezia 2.626
DE - Germania 2.384
UA - Ucraina 2.093
CN - Cina 1.343
FI - Finlandia 1.095
IT - Italia 1.008
HK - Hong Kong 601
IN - India 233
GB - Regno Unito 188
EU - Europa 70
IR - Iran 65
FR - Francia 60
CA - Canada 38
BE - Belgio 33
RU - Federazione Russa 25
NL - Olanda 24
SY - Repubblica araba siriana 17
RO - Romania 14
TR - Turchia 13
ES - Italia 8
IL - Israele 8
JP - Giappone 7
BG - Bulgaria 6
CH - Svizzera 6
VN - Vietnam 6
CZ - Repubblica Ceca 5
KR - Corea 5
SG - Singapore 4
AL - Albania 3
AT - Austria 3
BR - Brasile 3
CO - Colombia 3
MK - Macedonia 3
NG - Nigeria 3
PH - Filippine 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
DZ - Algeria 1
GR - Grecia 1
ID - Indonesia 1
IQ - Iraq 1
MX - Messico 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
TN - Tunisia 1
TW - Taiwan 1
Totale 32.135
Salva come PNG Salva come JPEG
Città #
Dublin 5.540
Jacksonville 3.928
Dearborn 1.869
Chandler 1.333
Wilmington 1.277
Lawrence 732
Princeton 732
Hong Kong 600
Beijing 581
San Mateo 564
Andover 379
Piemonte 371
Ashburn 308
Ann Arbor 301
Woodbridge 198
Houston 168
Boardman 166
Hefei 135
Düsseldorf 114
Philadelphia 114
Nanjing 107
Bremen 102
Kunming 96
Norwalk 91
Grafing 80
Jinan 52
Fairfield 50
Novara 49
Helsinki 46
Guangzhou 41
Seattle 38
Nanchang 37
Brussels 31
Zanjan 28
Rome 25
Falls Church 24
Milan 24
Shenyang 23
Toronto 22
Fuzhou 21
Turin 21
Leawood 20
Sacramento 19
Hangzhou 17
Tappahannock 17
Chengdu 16
Monmouth Junction 16
Wuhan 16
Strasbourg 15
Chongqing 14
Baotou 13
Cambridge 13
Berlin 12
Cassano Magnago 12
Hebei 12
Kocaeli 12
Torino 12
Horia 11
Lappeenranta 11
Salerno 10
Shaoxing 10
West Jordan 10
Naples 9
Zhengzhou 9
Auburn Hills 8
Augusta 8
Casalecchio Di Reno 8
Gunzenhausen 8
Palermo 8
Winnipeg 8
Xian 7
Brescia 6
Changsha 6
Dong Ket 6
Florence 6
Mumbai 6
Nanning 6
Redwood City 6
Shanghai 6
Vercelli 6
Ardabil 5
Chicago 5
Dallas 5
Henderson 5
Kolkata 5
Lucé 5
San Diego 5
Wenzhou 5
Alessandria 4
Asti 4
Bari 4
Dronten 4
Fort Worth 4
Jiaxing 4
Malappuram 4
Montréal 4
Ningbo 4
Perugia 4
Quzhou 4
Saint-Fons 4
Totale 20.921
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 137
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 110
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 105
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 100
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 98
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 97
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 94
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 93
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 87
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 87
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 85
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 84
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 79
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 78
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 78
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 76
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 76
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 76
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 75
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 75
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 75
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 74
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 74
ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES FROM LYMPHOMATOUS EFFUSIONS 74
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 73
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 73
KAPOSI's SARCOMA-ASSOCIATED HERPESVIRUS DNA SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS 73
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group 72
SAC I RFLP IN THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR GENE (IGF2R) ON HUMAN CHROMOSOME 6q 72
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 72
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 72
GROWTH- AND DIFFERENTIATION-ASSOCIATED EXPRESSION OF BCL-2 IN B-CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 71
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 70
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 69
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 69
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 68
Thrombotic Risk In Patients With Primary Immune Thrombocytopenia Is Only Mildly Increased And Explained By Personal And Treatment-Related Risk Factors 68
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 68
HIGH FREQUENCY OF EBV ASSOCIATION WITH NON-RANDOM ABNORMALITIES OF THE LONG ARM OF THE CHROMOSOME REGION 1q21-25 IN AIDS-RELATED BURKITT'S LYMPHOMA-DERIVED CELL LINES 67
IN VITRO ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES: PHENOTYPIC CHARACTERIZATION, ONCOGENE AND TUMOR SUPPRESSOR GENE LESIONS, AND HETEROGENEITY IN EPSTEIN-BARR VIRUS INFECTION 67
HIV-ASSOCIATED HHV-8 POSITIVE PRIMARY LYMPHOMATOUS EFFUSIONS: RADIOLOGICAL FINDINGS IN SIX PATIENTS 67
Outcome of therapy-related myeloid neoplasms treated with azacitidine 67
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 67
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 67
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 67
COMPARISON OF TWO REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION STRATEGIES FOR MINIMAL RESIDUAL DISEASE EVALUATION IN LYMPHOPROLIFERATIVE DISORDERS: CORRELATION BETWEEN IMMUNOGLOBULIN GENE MUTATION LOAD AND REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION PERFORMANCE 67
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 67
PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization 66
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 66
I RECETTORI DEI FATTORI DI CRESCITA EMOPOIETICI: STRUTTURA E MECCANISMI DI TRASDUZIONE DEL SEGNALE 66
IN VITRO STUDIES PROVIDE EVIDENCE THAT MULTIPLE PARACRINE LOOPS MAY BE OPERATING IN MULTIPLE MYELOMA 66
BIOLOGIC AND MOLECULAR CHARACTERIZATION OF NON-HODGKIN's LYMPHOMA 66
ROLE OF BONE MARROW STROMAL CELLS IN THE GROWTH OF MULTIPLE MYELOMA 66
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 66
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias. 65
PATOLOGIA MOLECOLARE 65
AIDS-RELATED NON-HODGKIN LYMPHOMAS. MOLECULAR GENETICS, VIRAL INFECTION, AND CYTOKINE DEREGULATION 65
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 65
PVUII RFLP IN THE CYTOVILLIN GENE (VIL2) ON HUMAN CHROMOSOME 6q 65
POINT MUTATIONS OF THE BCL-6 GENE IN BURKITT's LYMPHOMA 65
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 65
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma 65
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 65
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 65
DIAGNOSI E CLASSIFICAZIONE DEI LINFOMI NON-HODGKIN. BASI PATOLOGICHE, FENOTIPICHE E MOLECOLARI 64
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 64
MUTATIONS IN THE CODING REGION OF C-MYC OCCUR FREQUENTLY IN ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED LYMPHOMAS 64
DELETIONS INVOLVING TWO DISTINCT REGIONS OF 6q IN B-CELL NON-HODGKIN LYMPHOMA 64
BCL-6 PROTEIN EXPRESSION IN HUMAN PERIPHERAL T-CELL NEOPLASMS IS RESTRICTED TO CD30+ ANAPLASTIC LARGE CELL LYMPHOMAS 64
EXPRESSION PROFILE OF MUM1/IRF4, BCL-6, AND CD138/SYNDECAN-1 dEFINES NOVEL HISTOGENETIC SUBSETS OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED LYMPHOMAS 64
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 64
Prognostic relevance of MYD88 mutations in CLL: the jury is still out 64
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases. 63
LYMPHOID DISORDERS ASSOCIATED WITH HHV-8/KSHV INFECTION: FACTS AND CONTENTIONS 63
MUM-1: A STEP AHEAD TOWARD THE UNDERSTANDING OF LYMPHOMA HISTOGENESIS 63
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 63
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 63
AIDS-RELATED BURKITT's LYMPHOMA. MORPHOLOGIC AND IMMUNOPHENOTYPIC STUDY OF BIOPSY SPECIMENS 63
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. 63
CIRCULATING MALIGNANT PRECURSORS IN MONOCLONAL GAMMOPATHIES 62
RECENTI ACQUISIZIONI NELLA PATOGENESI DEI LINFOMI NON-HODGKIN 62
NUCLEOTIDE SEQUENCE, TRANSCRIPTION MAP AND MUTATION ANALYSIS OF THE 13q14 CHROMOSOMAL REGION DELETED IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 62
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 62
Na+/H+ EXCHANGE ACTIVATION MEDIATES THE LIPOPOLYSACCHARIDE-INDUCED PROLIFERATION OF HUMAN B LYMPHOCYTES AND IS IMPAIRED IN MALIGNANT B-CHRONIC LYMPHOCYTIC LEUKEMIA LYMPHOCYTES 62
The genetics of nodal marginal zone lymphoma 62
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 62
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 62
MOLECULAR PATHOGENESIS OF AIDS-RELATED LYMPHOMAS 61
CENTROMERIC INSTABILITY OF CHROMOSOME 1 RESULTING IN MULTIBRANCHED CHROMOSOMES, TELOMERIC FUSIONS, AND "JUMPING TRANSLOCATIONS" OF 1q IN A HUMAN IMMUNODEFICIENCY VIRUS-RELATED NON-HODGKIN's LYMPHOMA 61
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 61
AN APPARENT INTERLOCUS GENE CONVERSION-LIKE EVENT AT A PUTATIVE TUMOR SUPPRESSOR GENE LOCUS ON HUMAN CHROMOSOME 6q27 IN A BURKITT's LYMPHOMA CELL LINE 61
Molecular pathogenesis of chronic lymphocytic leukemia 61
Genetic determinants of response to warfarin. 61
Biology and treatment of Richter syndrome 61
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 61
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 61
SUBREGIONAL LOCALIZATION OF 20 SINGLE-COPY LOCI TO CHROMOSOME 6 BY FLUORESCENCE IN SITU HYBRIDIZATION 61
BIOLOGIC ASPECTS OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED LYMPHOMA 60
DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS OF GENETIC ALTERATIONS IN NON-HODGKIN's LYMPHOMA 60
POTENTIAL HETEROSEXUAL KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS TRANSMISSION IN A COUPLE WITH HIV-INDUCED IMMUNODEPRESSION AND WITH KAPOSI's SARCOMA AND MULTICENTRIC CASTLEMAN's DISEASE 60
Totale 7.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 163.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 163.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 0 14 6
2019/20206.890 8 11 657 8 1.146 1.172 1.582 344 769 452 729 12
2020/20214.584 685 32 675 15 640 54 707 33 710 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20242.210 241 214 246 76 585 51 630 78 23 41 25 0
Totale 32.874